38 related articles for article (PubMed ID: 22988701)
1. Cellular Responses to Extracellular Vesicles as Potential Markers of Colorectal Cancer Progression.
Guarnerio S; Tempest R; Maani R; Hunt S; Cole LM; Le Maitre CL; Chapple K; Peake N
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069076
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal women in gynecological care.
Pertyńska-Marczewska M; Pertyński T
Prz Menopauzalny; 2021 Jun; 20(2):88-98. PubMed ID: 34321987
[TBL] [Abstract][Full Text] [Related]
3. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.
Lee SHF; Abdul Rahman H; Abidin N; Ong SK; Leong E; Naing L
BMC Cancer; 2021 Apr; 21(1):477. PubMed ID: 33926405
[TBL] [Abstract][Full Text] [Related]
4. Determining the Risk Factors Affecting on Death Due to Colorectal Cancer Progression: Survival Analysis in the Presence of Competing Risks.
Safari M; Mahjub H; Esmaeili H; Abbasi M; Roshanaei G
J Gastrointest Cancer; 2022 Jun; 53(2):348-355. PubMed ID: 33656691
[TBL] [Abstract][Full Text] [Related]
5. S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway.
Ou S; Liao Y; Shi J; Tang J; Ye Y; Wu F; Wang W; Fei J; Xie F; Bai L
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355370
[TBL] [Abstract][Full Text] [Related]
6. Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro.
Chan KWK; Chung HY; Ho WS
Molecules; 2020 Jan; 25(1):. PubMed ID: 31947901
[No Abstract] [Full Text] [Related]
7. A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
Alatise OI; Ayandipo OO; Adeyeye A; Seier K; Komolafe AO; Bojuwoye MO; Afuwape OO; Zauber A; Omisore A; Olatoke S; Akere A; Famurewa O; Gonen M; Irabor DO; Kingham TP
Cancer; 2018 Jul; 124(13):2766-2773. PubMed ID: 29645077
[TBL] [Abstract][Full Text] [Related]
8. Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
Grizzi F; Basso G; Borroni EM; Cavalleri T; Bianchi P; Stifter S; Chiriva-Internati M; Malesci A; Laghi L
Inflamm Res; 2018 May; 67(5):375-389. PubMed ID: 29322204
[TBL] [Abstract][Full Text] [Related]
9. Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.
Qiu X; Feng JR; Wang F; Chen PF; Chen XX; Zhou R; Chang Y; Liu J; Zhao Q
Mol Med Rep; 2018 Feb; 17(2):3028-3034. PubMed ID: 29257257
[TBL] [Abstract][Full Text] [Related]
10. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer patients exhibit increased levels of galanin in serum and colon tissues.
Kwiatkowski P; Godlewski J; Kieżun J; Kraziński BE; Kmieć Z
Oncol Lett; 2016 Nov; 12(5):3323-3329. PubMed ID: 27899999
[TBL] [Abstract][Full Text] [Related]
12. Familial risk of colorectal cancer in subjects attending an organised screening programme.
Castiglione G; Visioli CB; Zappa M; Grazzini G; Mallardi B; Mantellini P
Dig Liver Dis; 2012 Jan; 44(1):80-3. PubMed ID: 21925983
[TBL] [Abstract][Full Text] [Related]
13. Improving detection of colorectal cancer.
Orbell J; West NJ
Practitioner; 2010 Oct; 254(1733):17-21, 2-3. PubMed ID: 21141248
[TBL] [Abstract][Full Text] [Related]
14. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
15. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
16. Early diagnosis improves survival in colorectal cancer.
Keane MG; Johnson GJ
Practitioner; 2012; 256(1753):15-8, 2. PubMed ID: 22988701
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
